FidoCure®

We're excited to share that our Founder and CEO, Christina Lopes was recently featured in Forbes! In this interview, Christina discusses her journey in building FidoCure and how the company provides cutting-edge targeted therapies to dogs, from humans. As Christina explains, dogs naturally develop many of the same cancers as humans, but their smaller size and faster disease progression allow researchers to study the full cancer journey. By first focusing on developing cutting-edge cancer treatments for our canine companions, the FidoCure team is helping thousands of dogs battling cancer. And in the process, they are uncovering insights that could profoundly impact the fight against human cancer as well. Check out the full Forbes feature to learn more about Christina's vision for FidoCure and the potential of comparative oncology: https://hubs.li/Q02M70PK0 #FidoCure #CancerResearch #Dogs #ForbesFeature

FidoCure's CEO Christina Lopes to showcase canine cancer breakthroughs at the KC Animal Health Corridor Summit! Our CEO, Christina Lopes, has been handpicked to present FidoCure's innovative approach to canine cancer treatment at the prestigious Animal Health Corridor Summit 2024 in Kansas City! This elite event spotlights the most prestigious research and medical companies in animal health, nutrition, diagnostics, and technology. It's a prime opportunity to connect with industry leaders and potential investors who can help us reach new heights in veterinary oncology. The Summit's pedigree speaks for itself: - Presenting companies have raised over $500 million - Many have secured licensing agreements, distribution contracts, or been acquired We're honored to be among the select few chosen to share our vision for the future of personalized medicine in veterinary oncology. Stay tuned as we prepare to unleash FidoCure's groundbreaking work next Monday in Kansas City! #CanineCancer #VeterinaryOncology #AnimalHealth #Innovation #FidoCure #PersonalizedMedicine #AnimalHealthCorridor

We are Rewriting the Future of Canine Cancer Care with our Newest USPTO Patent. We at FidoCure® are thrilled to share this next step in our fight against cancer. We've been granted a groundbreaking patent for an AI-driven approach that could transform how we care for dogs with cancer, particularly those battling bladder cancer. Every year, millions of families face the heartbreaking news of a cancer diagnosis for their beloved dogs. As veterinarians, you've been on the front lines, working tirelessly to provide the best care possible. Our new patented approach aims to give you more effective tools in this battle. It's not just a step forward; it's a leap into the future of precision medicine. By leveraging AI and real-world evidence from our network of 1,350 veterinary clinics, we're paving the way for more targeted treatments and this patent is just the beginning. We're committed to continuing our research and innovation with 8 more patents pending. To the veterinarians who dedicate their lives to animal health: thank you. Your expertise and compassion drive us forward. Together, we're opening new doors in canine cancer care, bringing renewed hope to countless families and their furry loved ones. https://hubs.li/Q02LjR1Z0 #CanineCancerCare #VeterinaryMedicine #PrecisionMedicine #FidoCure #Patented #USPTO

Our Founder and CEO Christina Lopes at the Nasdaq and Forbes studios yesterday talking about the lasting impact of FidoCure's work in canine cancer. Keep an eye out for more posts from us when the interview drops next month! Very proud of Christina for all her hard work in shining a light on FidoCure's mission to treat cancer on both ends of the leash 🐶

Congratulations to all of the nominees from the #WomeninAI awards last week! We are so proud to see our CEO and Founder Christina Lopes set a new precedent in veterinary oncology by being recognized for our work with AI. This wouldn't be possible without our partner James Zou at Stanford AI Health. Thank you to VentureBeat for having her! #VentureBeat #WomenInAI #VBTransform #AIinHealthcare #FidoCure

Congratulations to our inspiring leader, Christina Lopes, on her nomination for the Women in AI Award from VentureBeat! Christina is a testament to women pushing the boundaries of cancer care, and we're proud to see her recognized for her vision to bring AI to veterinary oncology. Check out the list here! https://hubs.li/Q02FKtSH0 #VentureBeats #WomenInAI #VBTransform #AIinHealthcare #PetTech

Join us for our fourth research presentation at the ACVIM Forum! We're thrilled to announce that FidoCure® is returning to the ACVIM Forum stage. This event is a cornerstone in the veterinary community, bringing together top experts from around the world. Our participation highlights FidoCure's cutting-edge advancements and significant impact on cancer research, improving lives on both ends of the leash. Don't miss the groundbreaking lecture by Dr. Lucas Rodrigues, our Head of Veterinary Research, "Precision Medicine in Canine Oncology: Unlocking the Potential of Small Molecule Targeted Therapy," on Saturday, June 8, 2024, from 11:30-12:30 CST. This lecture is a must-attend for anyone dedicated to advancing veterinary oncology. Small molecule targeted therapy holds incredible potential to transform the fight against canine cancer. Dr. Rodrigues will share our latest research and practical insights on how these therapies can revolutionize treatment, offering new hope for our canine companions. We hope to see you there! https://lnkd.in/gneM2tRE #fidocure #acvimforum #caninecancer #oncology

FidoCure® is thrilled to highlight the work of Dr. Cheryl London, a pioneer in veterinary oncology and targeted cancer therapies and member of our Scientific Board of Advisors. In a recent interview with Dr. Gerry Post, Dr. London discussed her role in developing Palladia® and other small molecule inhibitors over the past 25 years. These molecules have significantly advanced cancer care for pets and humans alike. Dr. London advocates for making these advanced treatments more accessible through primary care veterinarians to address the "access to care" crisis. At FidoCure, we are dedicated to supporting her vision by making innovative life-extending therapies available to more pets with cancer. Watch the interview to discover more about Dr. London's impactful work and our mission to revolutionize veterinary oncology. Together, we're creating new hope on both sides of the leash. https://lnkd.in/gyHZWd2p #FidoCure #VeterinaryOncology #TargetedTherapies #SmallMoleculeInhibitors #CanineCancer

Our Founder and CEO Christina Lopes featured in The Cancer Letter stressing the application of data and AI in the research of comparative oncology. Read the full article below to get insight into our mission and how AI is leading the fight against cancer on both ends of the leash.

Today on World Veterinary Day, we are so grateful for the 1100 veterinarians in over 1050+ clinics around the world who work tirelessly with FidoCure® to diagnose, treat, and manage cancer in dogs. Through our FidoCure platform, they provide cutting-edge treatments and personalized care for each canine patient in need. Together, we are at the forefront of the fight against canine cancer, offering hope and healing to dogs and their families. Thank you to all the veterinarians who make this possible including those featured below from FidoCure® pet parents across the globe. #worldveterinaryday #veterinarymedicine #fidocure